Pharmaceutical

Gamida Cell gets grant for method of preparing transplantable NK cell fraction for transplantation

Expand transplantable NK cell fractions for cancer treatment with Gamida Cell's patented method. Culturing, supplementing, and storing cells ensure improved outcomes for cancer patients.

Mar 30, 2024 - 00:00
Expand transplantable NK cell fractions for cancer treatment with Gamida Cell's patented method. Culturing, supplementing, and storing cells ensure improved outcomes for cancer patients.
Read the original article

Tags:

Previous Article

PTC Therapeutics gets grant for treatment of huntington’s disease using compound...

Next Article

Crinetics Pharmaceuticals gets grant for patent granted for somatostatin modulat...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: ‘Extraordinary’ survival data for lung cancer patients is seen as boost for AstraZeneca drug

STAT+: ‘Extraordinary’ survival data for lung cancer pa...

Jun 4, 2023

MSD’s Keytruda expands reach in lung cancer with neoadjuvant setting approval

MSD’s Keytruda expands reach in lung cancer with neoadj...

Oct 17, 2023

Morning Rounds: Americans put faith in nurses as overall confidence in health care ebbs

Morning Rounds: Americans put faith in nurses as overal...

Dec 21, 2023